News & Updates
Filter by Specialty:
Kids hard-hit by Delta; which ART performs best?
That COVID-19 mostly spared children might be changing. The Delta variant has taken a severe, unthinkable toll on kids – at least in Arkansas, US, reports an expert at IDWeek 2021.
Kids hard-hit by Delta; which ART performs best?
24 Oct 2021
Health status similar between sacubitril/valsartan and ramipril recipients post-acute MI
Patients who receive sacubitril-valsartan after an acute myocardial infarction (MI) have a similar health status, as determined by EQ-5D visual analog scale (VAS) score, compared with those who receive ramipril, according to results of a prespecified analysis of the PARADISE-MI trial presented at HFSA 2021.
Health status similar between sacubitril/valsartan and ramipril recipients post-acute MI
23 Oct 2021
Quality of life remains impaired after childhood bacterial meningitis
Survivors of bacterial meningitis (BM) suffer from an impaired health-related quality of life (HRQOL), regardless of possible disability, a study using parents’ perceptions has concluded.
Quality of life remains impaired after childhood bacterial meningitis
23 Oct 2021
Corticosteroids superior to IVIG in MIS-C myocardial damage due to COVID-19
Treatment with corticosteroids (CS) among children with multisystem inflammatory syndrome (MIS-C) cardiovascular involvement temporarily associated with COVID-19 leads to faster normalization of left ventricular ejection fraction (LVEF), fever, improved laboratory analysis, and shorter intensive care unit stay than treatment with intravenous immunoglobulin (IVIG), a study has shown.
Corticosteroids superior to IVIG in MIS-C myocardial damage due to COVID-19
22 Oct 2021
Bimekizumab maintains skin clearance in patients with plaque psoriasis
Maintenance treatment with bimekizumab achieves complete scalp, palmoplantar, or nail clearance in patients with moderate-to-severe plaque psoriasis, according to two phase III trials presented at EADV 2021.